ArticleMultiple sclerosis journal - experimental, translational and clinical
Safety reporting quality in multiple sclerosis clinical trials: A review of phase III clinical trials included in FDA approval of disease-modifying treatments.
William Z Lin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.